The invitation, obtained by CNBC, asked participants to join the Facebook health team in New York to learn about the company’s “new clinical trials strategy.”
“Learn how you can recruit patients and meet your clinical goals with Facebook’s products and solutions,” the invitation reads.
At the meeting, Facebook discussed ways pharmaceutical companies can and cannot recruit users, an anonymous source in attendance told CNBC. Marketers can target users based on demographics and interests — expressed via Facebook’s “like” feature — but not based on membership in Facebook groups, which sometimes focus on health-related issues.
More articles on supply chain:
Supply chain tip of the day: Consider seasonal indexes when demand planning
Hemophilia drug trial halted after patient death: 3 things to know
Novo Nordisk settles diabetes drug lawsuit for $58.7M: 3 things to know
